NTRR.US Neutra Corp

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 4, 2026
0.0001 0.0003
Market cap
USD 292K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.

Is NTRR.US undervalued?

Graham number

The Graham number of Neutra Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Neutra Corp fundamental analysis

No fundamental analysis for Neutra Corp yet.

Neutra Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Neutra Corp

Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space in the United States. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Houston, Texas.

Full company profile